First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

South African Regulator Recommends Lifting J&J Vaccine...

Newsdeck

Newsdeck

South African Regulator Recommends Lifting J&J Vaccine Ban

A healthcare worker removes vials containing doses of the Johnson & Johnson vaccine. Photo: Phill Magakoe/AFP/Getty Images
By Bloomberg
19 Apr 2021 0

(Bloomberg) --South Africa’s health regulator asked the government to lift the pause on administering Johnson & Johnson’s Covid-19 vaccine provided certain conditions are met.

By Felix Njini
Apr 17, 2021, 10:39 PM – Updated on Apr 18, 2021, 9:46 AM
Word Count: 166

“These conditions include, but are not limited to, strengthened screening and monitoring of participants who are at high risk of a blood clotting disorder,” the South African Health Products Regulatory Authority said in a statement.

South Africa halted J&J vaccines after health agencies on Tuesday called for their suspension in the U.S. The J&J shot is a key element to South Africa’s vaccination plan and has already been used to inoculate health workers, with no reported adverse effects. Drug maker Aspen Pharmacare Holdings Ltd. will manufacture the J&J vaccine in South Africa for wider use.

The government has been slow to rollout its vaccination program, and only 292,623 health-care workers had been inoculated with the J&J doses as of April 17. South Africa, which is the worst-affected country by the coronavirus pandemic on the continent, lags behind emerging market peers in vaccinations.

(Updates with slow rollout in final paragraph)
© 2021 Bloomberg L.P.
Information pertaining to Covid-19, vaccines, how to control the spread of the virus and potential treatments is ever-changing. Under the South African Disaster Management Act Regulation 11(5)(c) it is prohibited to publish information through any medium with the intention to deceive people on government measures to address COVID-19. We are therefore disabling the comment section on this article in order to protect both the commenting member and ourselves from potential liability. Should you have additional information that you think we should know, please email [email protected]
Gallery

Please peer review 3 community comments before your comment can be posted